ポイントオブケア（POC）診断検査の世界市場：第10版

当レポートでは、世界のポイントオブケア（POC）診断検査市場について調査し、市場の概要とともに、市場に影響を与える動向、技術概要、業界の課題、促進要因と抑制要因、市場規模と成長、及び市場に参入する企業のプロファイルなどをまとめています。

病院やリファレンスラボのラボ型分析装置で実施される検査がIVDの収益の基盤であることに変わりはありませんが、ポイントオブケアは常に成長分野と見なされてきました。Kalorama Informationがポイント・オブ・ケア診断の取材を始めてから20年になりますが、ポイント・オブ・ケア検査はそのチャンス領域と言えます。ポイント・オブ・ケアとは、その名の通り、医療機関の訪問時や患者の自宅での検査に意味があるものと定義されています

診断薬はどのようにウェルネスを促進するのか？　診断薬はどのように患者-医療者間の出会いを改善することができるのか？　検査によって、どのように薬剤の選択と管理を改善することができるのか？将来の患者宅や老人ホームを促進するために、どのように検査ができるのか？　次のパンデミックが発生したときに、適切に対処できるようにするにはどうしたらよいのでしょうか？　これらの質問に対する答えは、多くの点でポイント・オブ・ケアソリューションの成功に依存しています。

このような貢献により、ポイントオブケア診断薬は、経済的なラボベースの検査よりも高い価格設定と大きな収益成長を得ることができます。当レポートで取り上げた検査は、IVD市場全体よりも高い成長率を示す傾向にあります。

セグメンテーションの強化 - 多くのレポートを1つに集約

本レポートでカバーしている分野の一部をご紹介します：

• グルコース
• 凝固
• CRP
• その他の心臓マーカー
• 凝固
• 大腸がん
• 妊娠・不妊症
• 乱用される薬物
• hbA1c
• コレステロール
• HIV
• COVID-19
• その他の感染症
• クリティカルケア検査

当レポートでは、これらについて、市場規模や予測とともに詳しく解説しています

当レポートで取り上げたように、POC検査は過去20年間に急成長し、正確で迅速な検査に対する需要が病院内外で高まっています。世界のPOC検査市場を詳細に調査した結果、いくつかの興味深い事実が判明しましたので、本調査でご紹介します。スマートフォン、バイオセンサー、ラボオンチップ、ウェアラブルデバイスなどの新たな技術革新が、POCの状況に影響を与えています。健康分野におけるこれらの技術革新の原動力は、患者が受診する場所や患者の自宅で迅速な診断を提供することです。

会場市場の分析

POC検査は、以下のような幅広い地理的な場所で実施されます：

• 救急部、手術室、集中治療室などの病院部門
• 医師の診療所
• 病院内診療所
• 小売クリニック
• 薬局
• 家庭 - 患者、訪問看護師、またはその他の介護者が検査を行う場合
• 老人ホーム

POC検査は検査室の職員が行うこともあるが、多くの場合、医師、看護師、医療事務の助手、救急医療技師（EMT）、衛生士、薬剤師、患者自身（自己検査）など、検査室以外の職員によって行われます。POC検査の中には、ディップスティックやストリップ、ラテラルフローカセットなどに基づく技術で行われることが多い、手動式の検査もあります。また、POCの現場で使用するために開発された、小型で持ち運び可能な機器も数多くあります。近年起こった小型化とマイクロ流体工学の進歩により、小型でハンドヘルドな機器の数が増え、さまざまな検査アプリケーションのためにPOC市場に到達しつつあります。

地域別カバー率

POCは国際的な市場であり、Kaloramaは地域別カバレッジでこれを反映しています

分析は以下の地域に軸足を置いています：

• 欧州
• 日本
• 米国
• その他の地域

その他の国や地域は以下の通りです：

• オーストラリア
• カナダ
• 中国
• フランス
• ドイツ
• インド
• イタリア
• 韓国
• スペイン
• スウェーデン
• スイス
• 中南米
• 中東部

企業プロファイル

また、POC検査機器は過去10年間、診断薬市場全体の成長に大きく寄与してきました。より多くの診断薬メーカーが、POC検査機器のCLIA免除ステータスや、POCまたは自己使用のためのCEマークを追求しています。同時に、より多くの分散型検査機関が、免除されていない迅速検査や機器に投資しています。POC検査は、診断や患者ケアのモニタリングにおいて、さらに大きな役割を果たすようになってきているようです。新しい技術により、POC機器は、情報システム、相談のための遠隔介護サービス、または電子カルテに自動的に転送することができる定量的なラボ品質の検査結果を生成することができるようになってきています。迅速検査は、医師が診療所やオフィスを出る前に患者を治療することができるため、ポイントオブケア分野に組み込まれ始めています。

当レポートでは、ポイントオブケア検査について、セグメント別に解説しています

企業プロファイルで取り上げた上位および/または革新的な競合は以下の通りです：

調査手法と対象範囲

当レポートの地理的範囲は世界で、特定の地理的地域、世界の人口統計、その他市場に影響を与える一般的な問題についての情報を含んでいます。市場概要には、総市場価値、製品別、検査用途別、技術別、地域別、最終用途別の市場分析、主要プロバイダーの競合分析が含まれています。さらに、主要企業のプロファイルも含まれています。

すべての市場データは、メーカーレベルの世界市場に関するものです。市場には、サービスを除くメーカーテストが含まれます。データの基準年は2022年で、COVID-19パンデミックの影響に起因する更新と再検討を含みます。予測データは2022年から2026年まで提供されています。各分野の2022年から2026年までの年間平均成長率（CAGR）が提供されています。競合分析は、地域別内訳とともに2022年まで提供されています。2022-2026年の予測市場分析は、人口動態、新規開拓、革新的な技術、世界の拡大が主な要因となっています。

目次

第1章：エグゼクティブサマリー

• イントロダクション
• >範囲と調査手法
• 市場規模と成長
• 市場に影響を与える動向
• 競争力の見通し
• 市場の結論

第2章：イントロダクションと概要

• ポイントオブケア診断テスト
• 業界規制
• POC業界の促進要因
• POC業界の課題
• POC検査のタイプ
  • 血
  • 尿
  • 唾液
  • 髪
  • 光技術
  • 呼吸
• POC診断検査によって評価される症状
  • 癌
  • 大腸癌
  • 前立腺癌
  • 循環器疾患
  • 糖尿病
  • 薬物乱用
  • 感染症
  • ヘルペス
  • HTLV
  • RSウイルス
  • 肝炎
  • ライム病
  • バベシア症
  • 淋病、梅毒、クラミジア
  • 膣トリコモナス
  • HIV/エイズ
  • ヘリコバクター・ピロリ
  • インフルエンザ
  • コロナウイルス
  • 単核球症
  • 連鎖球菌
  • 骨粗鬆症
  • 妊娠と不妊

第3章：POC血糖検査

• 血糖検査のタイプ
  • 空腹時血糖（FBS）
  • 食後2時間血糖（PPBS）
  • ランダム血糖値
  • 耐糖能試験
  • グルコース尿検査
  • 糖化ヘモグロビン（HbA1c）
• 製品
• 市場規模と成長
• 競合分析

第4章：POC血液および電解質検査市場

• 血液検査と電解質検査タイプ
  • ヘモグロビン/ヘマトクリット
  • 白血球とその他
  • 血液ガス
  • 電解質
• 製品
• 市場規模と成長
• COVID-19の影響
• 競合分析

第5章：POC急速凝固

• 製品
• 市場規模と成長
• COVID-19の影響
• 競合分析

第6章：POC迅速心臓マーカー

• 製品
• 市場規模と成長
• COVID-19の影響
• 競合分析

第7章：POC薬物乱用

• 概要
• 製品
• 市場規模と成長
• COVID-19の影響
• 競合分析

第8章：POC妊娠および不妊検査

• 製品
• 市場規模と成長
• COVID-19の影響
• 競合分析

第9章：POC大腸癌検診・便潜血検査

• 製品
• 市場規模と成長
• COVID-19の影響
• 競合分析

第10章：POC感染症検査

• 製品
  • HIVと肝炎
  • 呼吸器
  • STD/STI
  • 熱帯病
  • ライム病
  • 結核（TB）
  • ジカ熱
  • 炭疽菌
  • その他のウイルス
  • 病院感染と敗血症
  • 敗血症
  • C.Diff
  • COVID-19
  • 抗原
  • 血清学
  • 分子
• 市場規模と成長

第11章：POC脂質試験

• 製品
• 市場規模と成長
• COVID-19の影響
• 競合分析

第12章：POC癌腫瘍マーカー検査

• 製品
• 市場規模と成長
• COVID-19の影響
• 競合分析

第13章：POC尿検査

• 製品
• 市場規模と成長
• COVID-19の影響
• 競合分析

第14章：その他のPOC検査

• 微生物学
• TSH
• アレルギー
• 自己免疫
• その他
• 市場規模と成長
  • 地域分析

第15章：問題と動向

• 概要
• ウェアラブル
• モバイルヘルスケアテクノロジー
• 遠隔医療
• 患者中心のヘルスケア
• 呼気検査の進歩
• 規制上のハードル
• 償還の課題
• PAMA
• 競合
• POCと分子診断
• POCバイオセンサーとマイクロフルイディクス
• POC市場としての中国
• 新たなPOC技術
• POC接続
• COVID-19の影響
• 多重POCテスト
• 非侵襲的技術の出現
• POCと抗生物質耐性の懸念
• POCにおける人工知能
• 感染症診断におけるPOCの未来
• サプライチェーンの遅延
• OTC診断検査の保険適用

第16章：全世界のPOCテスト市場と競合の分析

• 市場概要
• 製品カテゴリー別市場分析
• サブカテゴリー別市場分析
• デバイス技術別市場
• 国別市場分析
• COVID-19の影響
• 競合分析

第17章：会社概要

• 概要
• Step Detect Associates, LLC
• Abbott Laboratories
• Abingdon Health Ltd.
• AccessBio, Inc
• AccuBioTech Co, Ltd.
• ACON Laboratories, Inc
• Aerscher Diagnostics, LLC
• Alfa Scientific Designs, Inc
• American Bio Medica Corporation
• ARKRAY, Inc
• Artron Laboratories, Inc
• Ascensia Diabetes Care Holdings AG
• Atlas Link Biotech Co., Ltd
• Autobio Diagnostics Co., Ltd
• Beckman Coulter, Inc
• Becton Dickinson
• Beijing Wantai Biological Pharmacy Enterprise Co., Ltd
• Bhat Bio-Tech India Private Ltd.（BBI）
• bioLytical Laboratories
• BioMedomics, Inc
• Biomeme, Inc
• Biomerica, Inc
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• Biosensia Ltd
• Biotron Diagnostics, Inc
• Boditech Med Inc
• Boson Biotech Co. Ltd
• BTNX Inc
• Calypte Biomedical Corporation
• Cepheid, Inc
• Chembio Diagnostics, Inc
• Clarity Diagnostics, LLC
• CTK Biotech, Inc
• Cue Health
• Danaher Corporation
• Dexcom, Inc
• DIALAB GmbH
• DiaSys Diagnostic Systems GmbH
• Diazyme Laboratories, Inc.
• DNA Electronics Ltd.
• Dr.Fooke-Achterrath Laboratorien GmbH
• DxGen Corp.
• Eiken Chemical Co Ltd.
• EKF Diagnostics Holdings plc
• Enterix, Inc.
• Eurobio Scientific
• Exact Sciences
• EY Laboratories
• First Check Diagnostics LLC
• GeTein Biotech Inc
• GlysBy diagnostics
• Helena Laboratories.
• Hemosure, Inc.
• HORIBA, Ltd.
• Immune IQ
• Immunosciences Lab, Inc.
• Immunostics, Inc
• JAL Innovation PTE LTD
• Jant Pharmacal Corporation
• LamdaGen Corporation
• LifeScan, Inc
• LifeSign, LLC
• LightDeck Diagnostics
• LumiraDx UK Limited
• Macherey-Nagel GmbH &Co. KG
• MedMira, Inc
• Medtronic, Inc.
• Menarini Diagnostics srl.
• Meridian Bioscience, Inc
• MiCo BioMed USA
• Nano-Ditech Corporation
• NG Biotech
• Noble Medical, Inc
• Nova Biomedical Corp.
• Oasis Diagnostics Corporation
• Operon S.A
• OPKO Health, Inc
• OraSure Technologies, Inc.
• Polymedco, Inc
• Polymer Technologies, Inc（PTS Diagnostics）
• Preventis GmbH
• Princeton Biomeditech Corporation
• QuantuMDx Group Limited
• QuidelOrtho Corporation
• Radiometer Medical A/S
• Randox Laboratories Limited
• Response Biomedical Corp
• Reszon Diagnostics International Sdn. Bhd.
• Rheonix, Inc
• Roche Diagnostic Corporation
• Savyon Diagnostics
• Sekisui Diagnostics LLC
• Siemens Healthineers GmbH
• Sysmex Corporation
• TECHLAB, Inc
• Trinity Biotech PLC
• Trividia Health
• Tulip Diagnostics Ltd
• VedaLab
• Veredus Laboratories PTE Ltd
• Werfen

While tests run on lab-based analyzers in hospitals and reference labs remain the bedrock of IVD revenues, point of care has always been seen as the growth area. For as long as Kalorama Information has covered point of care diagnostics, and this now spans 2 decades, point of care tests are the opportunity area. Point of care as implied in the name is defined as tests that can be meaningful in a provider visit, or in the patients home.

How can diagnostics promote wellness? How can diagnostics improve patient-provider encounters? How can tests promote better selection and stewardship of drugs? How can tests facilitate patient home or nursing home of the future? How can diagnostics ensure the next pandemic, if and when it arrives is appropriately handled? The answers to these questions in many ways rely on the success of point-of-care solutions.

And because of this contribution, Point of Care diagnostics can earn a higher pricing and larger revenue growth than economized lab-based tests. The tests covered in this report tend to grow at higher rates than overall IVD market.

Enhanced Segmentation - Many Reports in One

Here are just some of the areas covered in this report:

• Glucose
• Coagulation
• CRP
• Other Cardiac Markers
• Coagulation
• Colon Cancer
• Pregnancy / Fertility
• Drugs of Abuse
• hbA1c
• Cholesterol
• HIV
• COVID-19
• Other Infectious Disease
• Critical Care Tests

These are detailed with market sizing and forecast in this report.

As discussed in this report, The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition, POC testing has skyrocketed in the last 20 years as demand for accurate and rapid testing has blossomed both inside and outside the hospital setting. An in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations in the health arena is to provide expedited diagnosis where the patient is seen or in the patient's home.

Venue Market Analysis

POC tests are performed in a wide range of geographical locations such as:

• Hospital departments such as emergency departments, operating rooms, intensive care units, and others

• Physicians' offices

• Hospital clinics

• Retail clinics

• Pharmacies

• Homes - With testing performed by patients, visiting nurses, or other caregivers

• Nursing homes

POC testing may be performed by laboratory personnel, but often it is performed by non-laboratory personnel such as physicians, nurses, assistants in medical offices, emergency medical technicians (EMTs), medics, pharmacists, and the patients themselves (self-testing). Some POC tests are manual tests, often performed with technologies based on dipsticks or strips, lateral flow cassettes, or other manual tests. There are also many small, portable instruments that have been developed for use in POC settings. With the advances in miniaturization and microfluidics that have occurred in recent years, a growing number of small, handheld devices are reaching the POC market for a range of different testing applications.

Regional Coverage

POC is an international market and Kalorama reflects this with regional coverage.

Analysis is anchored by:

• Europe
• Japan
• United States
• Rest of World

Other countries and regions discussed in the report include:

• Australia
• Canada
• China
• France
• Germany
• India
• Italy
• South Korea
• Spain
• Sweden
• Switzerland
• Latin America
• Middle East

Corporate Profiles

Moreover, POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. More diagnostic manufacturers have pursued CLIA waiver status for their POC devices and CE Mark for POC or self-use. At the same time, more decentralized test venues invest in non-waived rapid tests and instruments. POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care. New technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation or an electronic medical record. Rapid tests are beginning to fold into the point of care arena because they allow the physician to treat the patient before they leave the clinic or office.

This report breaks out point of care testing by segment.

Among the top and/or innovative competitors discussed within Corporate Profiles are:

Scope and Methodology

The geographic scope of The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 10th Edition is global, with information for specific geographical regions, world demographics, and other general issues affecting the market. The market summary includes total market values, market analysis by product, test usage, technology, region, end-use and a competitive analysis of leading providers. Additionally, key company profiles are included.

All market data pertains to the world market at the manufacturers' level. The market includes manufacturer tests excluding services. The base year for data was 2022, including updates and reexaminations stemming from the impact of the COVID-19 pandemic. Forecast data is provided for 2022 through 2026. Compound annual growth rates (CAGRs) are provided for 2022-2026 periods for each segment covered. Competitive analysis is provided for the year 2022 along with regional breakdowns. The forecasted market analysis for 2022-2026 was largely based on demographic trends, new developments, innovative technology and global expansion.

Table of Contents

Chapter 1: Executive Summary

Introduction

Scope and Methodology

Size and Growth of the Market

• Table 1-1: Global POC Test Market, 2022-2027 (in millions $ at manufacturer level)

Trends Affecting the Market

Competitive Outlook

Market Conclusions

• Conclusion One - POC market transformed by technological progress
• Conclusion Two - POC Molecular Diagnostics continue making inroads
• Conclusion Three - Prevention and early detection at nexus of POC development
• Conclusion Four - Wearables continue to influence POC market
• Conclusion Five - Test cost will continue to be an issue worldwide
• Conclusion Six - Rising demand will drive POC market in RoW markets
• Conclusion Seven - New venues - urgent & retail care
• Conclusion Eight - COVID-19's positive effect
• Conclusion Nine - Insurance coverage for OTC COVID-19 testing
• Conclusion Ten - New Opportunities in POC Infectious Disease Testing
• Conclusion Eleven - Supply Chain Delays
• Conclusion Twelve - Multiplex Testing Explodes
• Conclusion Thirteen - AI Making Inroads into POC

Chapter 2: Introduction and Overview

Point-of-Care Diagnostics Testing

Industry Regulations

• Types of CLIA Certificates

POC Industry Drivers

• Patient focused drivers
• Medical/Healthcare related drivers
• Technology drivers
• Economic drivers
• Other drivers

POC Industry Challenges

POC Test Types

• Blood
• Urine
• Saliva
• Hair
• Optical Technologies
• Breath

Conditions Evaluated by POC Diagnostic Testing

• Cancer
• Colorectal Cancer
• Prostate Cancer
• Cardiovascular Disease
• Diabetes
• Drug Abuse
• Infectious Disease
• Herpes
• HTLV
• Respiratory Syncytial Virus
• Hepatitis
• Lyme Disease
• Babesiosis
• Gonorrhea, Syphilis and Chlamydia
• Trichomonas Vaginalis
• HIV/AIDS
• Helicobacter Pylori
• Influenza
• Coronavirus
• Mononucleosis
• Streptococcus
• Osteoporosis
• Pregnancy and Fertility

Chapter 3: POC Blood Glucose Tests

Types of Blood Glucose Testing

• Fasting Blood Sugar (FBS)
• 2-Hour Postprandial Blood Sugar (PPBS)
• Random Blood Sugar
• Glucose Tolerance Test
• Glucose Urine Test
• Glycated Hemoglobin (HbA1c)

Products

• Blood Glucose Self-Testing
  • Table 3-1: Selected Glucose Self-Test Meter Innovations
  • Table 3-2: Selected Apps and Glucose Management IT
• Continuous Self-Testing
• Glycated Hemoglobin Tests
  • Table 3-3: Selected POC HbA1c Devices
• Professional

Market Size and Growth

• Table 3-4: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)
• Table 3-5: Global POC Diabetes Sales by Test Category, 2022-2027 (Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; $ millions)
• Regional Analysis
  • Figure 3-1: POC Blood Glucose Testing Regional Market Analysis, 2022 (%)
• POC Glucose Self-Testing
  • Table 3-6: Global POC Glucose Self-Testing Market (excludes continuous glucose devices) 2022-2027 (in millions $ at manufacturer level)
• POC Continuous Glucose Self-Testing
  • Table 3-7: Global POC Continuous Glucose Self-Testing Market 2022-2027 (in millions $ at manufacturer level)
• POC Glucose Professional Testing
  • Table 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing) 2022-2027 (in millions $ at manufacturer level)
• POC HbA1c Testing
  • Table 3-9: Global POC Glucose HbA1c Professional Testing Market 2022-2027 (in millions $ at manufacturer level)
• COVID-19 Impact

Competitive Analysis

• Table 3-10: Global POC Blood Glucose Testing Market (BGM, CGM,HbA1c) Revenues and Market Share of Leading Suppliers (Abbott, Ascensia, Dexcom, LifeScan, Medtronic, Roche, Others), 2022 (in millions $)
• Figure 3-2: Global POC Glucose Test Manufacturers (Abbott, Ascensia, Dexcom, LifeScan, Medtronic, Roche, Others), by Percent, 2022 (%)

Chapter 4: POC Blood and Electrolytes Testing Market

Types of Blood and Electrolytes Tests

• Hemoglobin/Hematocrit
• WBC and Other
• Blood Gases
• Electrolytes

Products

• Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2022
• Table 4-2: Selected POC Hematology Analyzer Systems, 2022

Market Size and Growth

• Table 4-3: Global POC Blood and Electrolytes Testing (Blood Gases/Electrolytes, Hemoglobin/Hematocrit, WBC, Market Analysis), 2022-2027 (in millions of dollars at the manufacturer's level)
• Table 4-4: Global POC Blood & Electrolytes Revenues by Test Category (Blood Gases & Electrolytes, Hematocrit/Hemoglobin, WBC other routine) 2022-2027 ($ millions)
• Regional Analysis
  • Figure 4-1: POC Blood and Electrolytes Testing Regional Market (US, Europe, Japan, Rest of World) Analysis 2022 (%)
• POC Blood and Electrolyte Self-Testing
  • Table 4-5: Global POC Blood and Electrolyte Self Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)
• POC Blood and Electrolyte Professional Testing
  • Table 4-6: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)

COVID-19 Impact

Competitive Analysis

• Table 4-7: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers (Abbott, Beckman Coulter, Radiometer, Siemens Healthineers, Sysmex, Other), 2022 (in millions $)
• Figure 4-2: Global POC Blood and Electrolyte Testing Market Manufacturers (Abbott, Beckman Coulter, Radiometer, Siemens Healthineers, Sysmex, Other), by Percent, 2022

Chapter 5: POC Rapid Coagulation

Products

• Table 5-1: Selected POC Coagulation Test Innovations
• Platelet Testing
  • Table 5-2: Selected Platelet Activity Test Innovations

Market Size and Growth

• Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)
• Regional Analysis
  • Figure 5-1: POC Rapid Coagulation Testing Regional (US, Europe, Japan, Rest of World) Market Analysis 2022 (%)
• POC Rapid Coagulation Self-Testing
  • Table 5-4: POC Rapid Coagulation Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)
• POC Rapid Coagulation Professional Testing
  • Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)

COVID-19 Impact

Competitive Analysis

• Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers (Abbott, Radiometer, Roche Diagnostics, Siemens Healthineers, Werfen, Others), 2022 (in millions$)
• Figure 5-2: Global POC Rapid Coagulation Testing Market, Market Share % of Leading Suppliers (Abbott, Radiometer, Instrumentation Labs, Roche Diagnostics, Siemens Healthineers, Others), 2022

Chapter 6: POC Rapid Cardiac Markers

Products

Market Size and Growth

• Table 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)
• Regional Analysis
  • Figure 6-1: POC Rapid Cardiac Markers Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)

COVID-19 Impact

Competitive Analysis

• Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers (Abbott, QuidelOrtho, Roche, Siemens Healthineers, Others), 2022 (in millions $)
• Figure 6-2: Global POC Cardiac Markers Test Manufacturers (Abbott, QuidelOrtho, Roche, Siemens, Others), by Percent, 2022

Chapter 7: POC Substance Abuse

Overview

Products

• Urine
• Oral
• Blood
• Hair

Market Size and Growth

• Table 7-1: Global POC Drugs of Abuse Testing (critical care, employment and criminal) Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)
• Regional Analysis
  • Figure 7-1: POC Substance Abuse Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
• POC Drugs of Abuse Self-Testing
  • Table 7-2: Global POC Drugs of Abuse Self Testing Market, 2022-2027 ($ millions at the manufacturer's level)
• POC Drugs of Abuse Professional Testing
  • Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)

COVID-19 Impact

Competitive Analysis

• Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers (Abbott, Roche, Siemens Healthineers, ThermoFisher, Others), 2022 (in millions of $)
• Figure 7-2: Global POC Drug of Abuse Testing Manufacturers (Abbott, Roche, Siemens Healthineers, ThermoFisher, Others), by Percent, 2022

Chapter 8: POC Pregnancy and Fertility Testing

Products

• Table 8-1: Selected Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay), Manufacturer's Instrument / Device / Assay

Market Size and Growth

• Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)
• Regional Analysis
  • Figure 8-1: POC Pregnancy and Fertility Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
• POC Pregnancy and Fertility Self-Testing
  • Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)
• POC Pregnancy and Fertility Professional Testing
  • Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)

COVID-19 Impact

Competitive Analysis

• Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers (bioMérieux, Church & Dwight, Meridian, Quidel, SPD, Others), 2022 (in millions $)
• Figure 8-2 Global POC Pregnancy and Fertility Testing Manufacturers (bioMérieux, Church & Dwight, Meridian, QuidelOrtho, SPD, Others), by Percent, 2022

Chapter 9: POC Colon Cancer Screening/Fecal Occult Blood Testing

Products

• Table 9-1: Selected POC Colon Cancer Tests

Market Size and Growth

• Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis: 2022-2027 (in millions of dollars at the manufacturer's level)
• Regional Analysis
  • Figure 9-1: POC Colon Cancer Screening/FOB Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
• POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
  • Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)
• POC Colon Cancer Screening/ Fecal Occult Blood Professional Testing
  • Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)

COVID-19 Impact

Competitive Analysis

• Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers (Beckman Coulter, Exact Sciences, Others), 2022 (in millions $)
• Figure 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers (Beckman Coulter, Exact Sciences, Others), by Percent, 2022

Chapter 10: POC Infectious Disease Testing

Products

• HIV and Hepatitis
• Respiratory
• STD/STI
• Tropical Diseases
• Lyme Disease
• Tuberculosis (TB)
• Zika
• Anthrax
• Other Viruses
• Hospital Acquired Infections and Sepsis
• Sepsis
• C.Diff
  • Table 10-1: Selected Innovations in POC Infectious Disease Diagnostics
• COVID-19
• Antigen
• Serology
• Molecular

Market Size and Growth

• Table 10-2: Global POC Infectious Disease (including COVID-19) Testing Market Analysis: 2022-2027 (in millions of dollars at the manufacturer's level)
• Regional Analysis
  • Figure 10-1: POC Infectious Disease (including COVID-19) Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
• POC Infectious Disease Self-Testing
  • Table 10-3: POC Infectious Disease Self-Testing(including COVID-19) Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)
• POC Infectious Disease Professional Testing
  • Table 10-4: POC Infectious Disease (including COVID-19) Professional Testing Market Analysis, 2022-2027(in millions of dollars at the manufacturer's level)
• POC Infectious Disease Testing by Disease Type
  • Table 10-5: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market by Disease Type (C. difficile, COVID-19, E. coli, H. pylori, Hepatitis, HIV, Home Test/OTC, Influenza. Malaria, Other Respiratory, STD, Others), 2022 (in millions $)
  • Figure 10-2: Global POC Infectious Disease (COVID-19, Influenza, HIV, STD, Hepatitis, Malaria, C. Diff, E. coli, H. pylori, Home Test/OTC, Others) Percent by Disease Type 2022
  • Figure 10-3: Global Selected POC Infectious Disease (COVID-19, Respiratory, HIV, STD, Hepatitis, C. Diff), Percent by End-user (Hospital including reference labs, physician office labs (POL) and Nursing Homes, pharmacy, home use and others), 2022
• Competitive Analysis
  • Table 10-6: Global POC Infectious Disease including COVID-19 Testing Market, Revenues and Market Share of Leading Suppliers (Abbott, Becton Dickinson, OraSure, QuidelOrtho, Roche, Siemens Healthineers, Others), 2022 (in millions $)
  • Figure 10-4: Global POC Infectious Disease Test Manufacturers (Abbott, Becton Dickinson, OraSure, QuidelOrtho, Roche, Siemens Healthineers, Others), by Percent, 2022

Chapter 11: POC Lipid Testing

Products

Market Size and Growth

• Table 11-1: Global POC Lipid Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)
• Regional Analysis
  • Figure 11-1: POC Lipid Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
• POC Lipid Self-Testing
  • Table 11-2: POC Lipid Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)
• POC Lipid Professional Testing
  • Table 11-3: POC Lipid Professional Testing Market Analysis, 2022-2027(in millions of dollars at the manufacturer's level)

COVID-19 Impact

Competitive Analysis

• Table 11-4: Global POC Lipid Testing Market, Revenues and Market Share of Leading Suppliers 2022 (in millions $)
• Figure 11-2: Global POC Lipid Testing Manufacturers (Abaxis/Zoetis, Abbott, Roche, Others), by Percent, 2022 (%)

Chapter 12: POC Cancer Tumor Marker Testing

Products

• Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications

Market Size and Growth

• Table 12-2: Global POC Cancer Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)
• Regional Analysis
  • Figure 12-1: POC Cancer Tumor Marker Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)

COVID-19 Impact

• Competitive Analysis
  • Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers (Beckman Coulter, bioMérieux, QuidelOrtho, Others), 2022 (in millions $)
  • Figure 12-2: Global POC Cancer Testing Manufacturers (Beckman Coulter, bioMérieux, QuidelOrtho, Others), by Percent, 2022

Chapter 13: POC Urine Testing

Products

Market Size and Growth

• Table 13-1: Global POC Urine Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)
• Regional Analysis
  • Figure 13-1: POC Urine Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)
• POC Urine Self-Testing
  • Table 13-2: POC Urine Self-Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)
• POC Urine Test Professional Testing
  • Table 13-3: POC Urine Professional Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)

COVID-19 Impact

Competitive Analysis

• Table 13-4: Global POC Urine Testing Market, Revenues and Market Share of Leading Suppliers (Eiken Chemical, Roche, Siemens Healthineers, Sysmex, Others), 2022 (in millions $)
• Figure 13-2: Global POC Urine Strip Testing Manufacturers (Eiken Chemical, Roche, Siemens Healthineers, Sysmex, Others), by Percent, 2022

Chapter 14: Miscellaneous POC Testing

Microbiology

TSH

Allergy

Autoimmune

Others

Market Size and Growth

• Table 14-1: Global Miscellaneous POC Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)
• Table 14-2: Global POC Miscellaneous Sales, by Test Category (Microbiology, TSH, Allergy, Autoimmune, Others), 2022-2027 ($ millions)
• Regional Analysis
  • Figure 14-1: POC Miscellaneous Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2022 (%)

Chapter 15: Issues and Trends

Overview

Wearables

• Table 15-1: Selected Wearable Devices

Mobile Healthcare Technologies

Telehealth

• Telehealth eMed to Implement Home Test to Treat Program

Patient-centered Healthcare

Breath Test Advances

• Table 15-2: Selected Disease Markers in Exhaled Breath

Regulatory Hurdles

Reimbursement Challenges

PAMA

Competition

POC and Molecular Diagnostics

• Table 15-3: Selected Market Available Molecular POC Diagnostic Platforms

POC Biosensors and Microfluidics

• Table 15-4: Selected FDA-Approved Microfluidic-based POC Tests 2022
• Table 15-5: Selected Biochip and Biosensor Players, 2022

China as a POC Market

Emerging POC Technologies

POC Connectivity

COVID-19 Impact

Multiplexed POC Testing

• Figure 15-1: Multiplexed POC Testing Schematic

The Emergence of Non-invasive Technologies

• Saliva and Swab
• Optical Techniques
• Near-infrared Scanning
• Volatolomics

POC and Antibiotic Resistance Concern

Artificial Intelligence in POC

POC Future in Infectious Disease Diagnostics

Supply Chain Delays

Insurance Coverage for OTC Diagnostic Tests

Chapter 16: Total Global POC Testing Market and Competitor Analysis

Market Overview

• Table 16-1: Global POC Test Market, 2022-2027 (in millions $ at manufacturer level)

Market Analysis by Product Categories

• Table 16-2: Global POC Testing Market Analysis by Product Category (Self-Testing, Professional Testing), 2022 (in millions $)

Market Analysis by Subcategory

• POC Self-Testing
  • Table 16-3: Global POC Self-Testing Market Analysis by Product Category (Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose including CGM, Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Other), 2022 (in millions$)
  • Figure 16-1: Global POC Self-Testing Market Analysis by Product Category (Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose including CGM, Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Other), 2022 (%)
• POC Professional Testing
  • Table 16-4: Global POC Professional Testing Market Analysis by Product Subcategory (Blood and Electrolytes, Cancer Tumor Markers, Cardiac Markers, Drugs of Abuse, Fecal Occult Blood, Glucose includes HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Rapid Coagulation, Urine, Miscellaneous), 2022 (in millions$)
  • Figure 16-2 : Global POC Professional Testing Market Analysis by Product Subcategory (Blood and Electrolytes, Cancer Tumor Markers, Cardiac Markers, Drugs of Abuse, Fecal Occult Blood, Glucose/HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Rapid Coagulation, Urine, Other), 2022 (by %)
• POC Testing by End-Use
  • Figure 16-3: POC Testing by End-User (Hospitals and Reference Labs, Nursing Homes/Pharmacies/Home, Physician Office Labs), 2022

Market by Device Technology

• Figure 16-4: Global POC Market by Technology (Analyzers, Biosensor, LFA, Strips), by Sales 2022 by %

Market Analysis by Country

• United States
  • Table 16-5: US POC Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)
• Europe
  • Table 16-6: Europe POC Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)
  • Table 16-7: Global POC Testing Market Analysis by European Region, 2022 (in millions $)
• Germany
• France
• UK
• Switzerland and Sweden
• Other
  • Figure 16-5: Europe POC Testing Percentage Participation, by Country (France, Germany, Italy, Spain, Switzerland, Sweden, United Kingdom, Others), 2022 (%)
• Japan
  • Table 16-8: Japan POC Testing Market Analysis, 2022-2027 (in millions of dollars at the manufacturer's level)
• Rest of World
• Latin America
• China
• India
• South Korea
• Other RoW Countries
  • Table 16-9: Global POC Testing Market Analysis by Rest of World Region/Country (Australia, China, India, Latin America/Middle East/Canada, South Korea/Other Asian Countries, Other), 2022 (in millions $)
  • Figure 16-6: Global POC Testing Market Analysis by Rest of World Region/Country (Australia, China, India, Latin America, South Korea, Other), 2022 (%)
  • Table 16-10: Global POC Testing Analysis by Region/Country (Europe, Japan, United States, Rest of World), 2022 (in millions $)
  • Figure 16-7: Global POC Testing Market Analysis Percent by Region/Country (Europe, Japan, United States, Rest of World), 2022 (%)

COVID-19 Impact

Competitive Analysis

• Table 16-11: Global POC Testing Market Revenues and Market Share of Leading Suppliers (Abbott, Ascensia, Beckman Coulter, Becton Dickinson, Dexcom, Exact Sciences, Lifescan, Medtronic, QuidelOrtho, Radiometer, Roche, Siemens Healthineers, Sysmex, Thermo Fisher, Others), 2022 (in millions $)
• Figure 16-8: Global POC Testing Market Share by Leading Suppliers (Abbott, Ascensia, Beckman Coulter, Becton Dickinson, bioMérieux, Dexcom, Exact Sciences, Lifescan, Medtronic, QuidelOrtho, Radiometer, Roche, Siemens Healthineers, Sysmex, Thermo Fisher, Others), 2022 (%)

Chapter 17: Corporate Profiles

Overview

1 Step Detect Associates, LLC

• Table 17-1: 1-Step Detect Associates Corporate Summary
• Company Overview
• Products

Abbott Laboratories

• Table 17-2: Abbott Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-3: Abbott Revenues 2020-2022 (in millions $)

Abingdon Health Ltd.

• Table 17-4: Abingdon Health Corporate Summary
• Company Overview
• Products
• COVID-19

AccessBio, Inc.

• Table 17-5: AccessBio Corporate Summary
• Company Overview
• Products
• COVID-19

AccuBioTech Co, Ltd.

• Table 17-6: AccuBioTech Corporate Summary
• Company Overview
• Products
• COVID-19

ACON Laboratories, Inc

• Table 17-7: ACON Laboratories Corporate Summary
• Company Overview
• Products
• COVID-19

Aerscher Diagnostics, LLC

• Table 17-8: Aerscher Diagnostics Corporate Summary
• Company Overview
• Products

Alfa Scientific Designs, Inc

• Table 17-9: Alfa Scientific Corporate Summary
• Company Overview
• Products
• COVID-19

American Bio Medica Corporation

• Table 17-10: American Bio Medica Corporate Summary
• Company Overview
• Products
• COVID-19

ARKRAY, Inc.

• Table 17-11: ARKRAY Corporate Summary
• Company Overview
• Products

Artron Laboratories, Inc

• Table 17-12: Artron Laboratories Corporate Summary
• Company Overview
• Products
• COVID-19

Ascensia Diabetes Care Holdings AG

• Table 17-13: Ascensia Diabetes Care Corporate Summary
• Company Overview
• Products

Atlas Link Biotech Co., Ltd

• Table 17-14: Atlas Link Biotech Corporate Summary
• Company Overview
• Products
• COVID-19

Autobio Diagnostics Co., Ltd

• Table 17-15: Autobio Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19

Beckman Coulter, Inc

• Table 17-16: Beckman Coulter Corporate Summary
• Company Overview
• Products
• COVID-19
• Company Financials
  • Table 17-17: Beckman Coulter Revenue (2020-2022) ($ millions)

Becton Dickinson (BD)

• Table 17-18: BD Corporate Summary
• Company Overview
• Products
• COVID-19
• Company Financials
  • Table 17-19: BD Corporation Revenue (2020-2022) ($ millions)

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

• Table 17-20: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
• Company Overview
• Products
• COVID-19

Bhat Bio-Tech India Private Ltd. (BBI)

• Table 17-21: Bhat Bio-Tech India Private Corporate Summary
• Company Overview
• Products
• COVID-19
• binx health
  • Table 17-22: binx health Corporate Summary
• Company Overview
• Products
• COVID-19

bioLytical Laboratories

• Table 17-23: bioLytical Laboratories Corporate Summary
• Company Overview
• Products
• COVID-19

BioMedomics, Inc

• Table 17-24: BioMedomics Corporate Summary
• Company Overview
• Products
• COVID-19

Biomeme, Inc

• Table 17-25: Biomeme Corporate Summary
• Company Overview
• Products

Biomerica, Inc.

• Table 17-26: Biomerica Corporate Summary
• Company Overview
• Products
• COVID-19
• Company Financials
  • Table 17-27: Biomerica Corporation Revenue (2020-2022) ($ millions)

bioMérieux SA

• Table 17-28: bioMerieux SA Corporate Summary
• Company Overview
• Products
• COVID-19
• Company Financials
  • Table 17-29: bioMerieux Revenues (2020-2022) ($ millions)

Bio-Rad Laboratories Inc.

• Table 17-30: Bio-Rad Labs Corporate Summary
• Company Overview
• Products
• Company Financials
  • Table 17-31: Bio-Rad Corporation Revenue (2020-2022) ($ millions)

Biosensia Ltd.

• Table 17-32: Biosensia Corporate Summary
• Company Overview
• Products

Biotron Diagnostics, Inc.

• Table 17-33: Biotron Diagnostics Corporate Summary
• Company Overview
• Products

Boditech Med Inc

• Table 17-34: Boditech Med Corporate Summary
• Company Overview
• Products
• COVID-19

Boson Biotech Co. Ltd

• Table 17-35: Boson Biotech Corporate Summary
• Company Overview
• Products
• COVID-19

BTNX Inc.

• Table 17-36: BTNX Corporate Summary
• Company Overview
• Products
• COVID-19

Calypte Biomedical Corporation

• Table 17-37: Calypte Biomedical Corporate Summary
• Company Overview
• Products

Cepheid, Inc

• Table 17-38: Cephid Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-39: Cepheid Revenues (2020-2022) ($ millions)

Chembio Diagnostics, Inc.

• Table 17-40: Chembio Diagnostic Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-41: Chembio Diagnostics Revenues (2020-2022) ($ millions)
• Church & Dwight Co. Inc
  • Table 17-42: Church & Dwight Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-43: Church and Dwight Revenues (2020-2022) ($ millions)

Clarity Diagnostics, LLC

• Table 17-44: Clarity Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19
• Confirm Biosciences
  • Table 17-45: Confirm Biosciences Corporate Summary
• Company Overview
• Products
• COVID-19

CTK Biotech, Inc.

• Table 17-46: CTK Biotech Corporate Summary
• Company Overview
• Products
• COVID-19

Cue Health

• Table 17-47: Cue Health Corporate Summary
• Company Overview
• Products
• COVID-19

Danaher Corporation

• Table 17-48: Danaher Corporation Summary
• Company Overview
• Products

Dexcom, Inc

• Table 17-49: Dexcom Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-50: Dexcom Revenues (2020-2022) ($ millions)

DIALAB GmbH

• Table 17-51: DIALAB Corporate Summary
• Company Overview
• Products
• COVID-19

DiaSys Diagnostic Systems GmbH

• Table 17-52: DiaSys Diagnostic Systems Corporate Summary
• Company Overview
• Products
• COVID-19

Diazyme Laboratories, Inc.

• Table 17-53: Diazyme Laboratories Corporate Summary
• Company Overview
• Products
• COVID-19

DNA Electronics Ltd. (DNAe)

• Table 17-54: DNA Electronics Corporate Summary
• Company Overview
• Products

Dr. Fooke-Achterrath Laboratorien GmbH

• Table 17-55: Dr. Fooke-Achterrath Laboratorien Corporate Summary
• Company Overview
• Products
• COVID-19

DxGen Corp.

• Table 17-56: DxGen Corporate Summary
• Company Overview
• Products
• COVID-19

Eiken Chemical Co Ltd.

• Table 17-57: Eiken Chemical Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-58: Eiken Chemical Revenues (2020-2022 ($ millions)

EKF Diagnostics Holdings plc

• Table 17-59: EKF Diagnostics Corporate Summary
• Company Overview
• Products
• ELITechGroup S.A.S.
  • Table 17-60: ELITechGroup Corporate Summary
• Company Overview
• Products
• COVID-19

Enterix, Inc. (Clinical Genomics)

• Table 17-61: Enterix Corporate Summary
• Company Overview
• Products

Eurobio Scientific

• Table 17-62: Eurobio Scientific Corporate Summary
• Company Overview
• Products
• COVID-19
• Everlywell
  • Table 17-63: Everlywell Corporate Summary
• Company Overview
• Products
• COVID-19

Exact Sciences

• Table 17-64: Exact Sciences Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-65: Exact Sciences Revenues (2020-2022) ($ millions)

EY Laboratories

• Table 17-66: EY Laboratories Corporate Summary
• Company Overview
• Products

First Check Diagnostics LLC

• Table 17-67: First Check Diagnostics Corporate Summary
• Company Overview
• Products
• GenBio
  • Table 17-68: GenBio Corporate Summary
• Company Overview
• Products
• Genedrive plc
  • Table 17-69: Genedrive Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-70: Genedrive Revenues (2020-2022) ($ millions)

GeTein Biotech Inc.

• Table 17-71: GeTein Corporate Summary
• Company Overview
• Products
• COVID-19

GlysBy diagnostics

• Table 17-72: GlysBy Corporate Summary
• Company Overview
• Products

Helena Laboratories

• Table 17-73: Helena Laboratories Corporate Summary
• Company Overview
• Products

Hemosure, Inc.

• Table 17-74: Hemosure Corporate Summary
• Company Overview
• Products

HORIBA, Ltd.

• Table 17-75: HORIBA Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-76: HORIBA Revenues (2020-2022) ($ millions)

Immune IQ

• Table 17-77: Immune IQ Corporate Summary
• Company Overview
• Products

Immunosciences Lab, Inc.

• Table 17-78: Immunosciences Lab Corporate Summary
• Company Overview
• Products

Immunostics, Inc

• Table 17-79: Immunostics Corporate Summary
• Company Overview
• Products
• COVID-19

JAL Innovation PTE LTD

• Table 17-80: JAL Innovation Corporate Summary
• Company Overview
• Products

Jant Pharmacal Corporation

• Table 17-81: Jant Pharmacal Corporate Summary
• Company Overview
• Products
• Mitra & Co Pvt. Ltd
  • Table 17-82: J Mitra Corporate Summary
• Company Overview
• Products
• Covid-19

LamdaGen Corporation

• Table 17-83: LamdaGen Corporate Summary
• Company Overview
• Products
• COVID-19

LifeScan, Inc

• Table 17-84: LifeScan Corporate Summary
• Company Overview
• Products

LifeSign, LLC

• Table 17-85: LifeSign Corporate Summary
• Company Overview
• Products
• COVID-19

LightDeck Diagnostics

• Table 17-86: LightDeck Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19

LumiraDx UK Limited

• Table 17-87: LumiraDx Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-88: LumiraDx (2020-2022) ($ millions)

Macherey-Nagel GmbH & Co. KG

• Table 17-89: Macherey-Nagel Corporate Summary
• Company Overview
• Products
• Medix Biochemica
  • Table 17-90: Medix Biochemica Corporate Summary
• Company Overview
• Products
• COVID-19

MedMira, Inc

• Table 17-91: MedMira Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-92: MedMira Revenues (2020-2022) ($ thousands)

Medtronic, Inc.

• Table 17-93: Medtronic Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-94: Medtronic Revenues (2017-2020) ($ millions)

Menarini Diagnostics srl.

• Table 17-95: Menarini Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19

Meridian Bioscience, Inc

• Table 17-96: Meridian Bioscience Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-97: Meridian Bioscience (2020-2022) ($ millions)

MiCo BioMed USA

• Table 17-98: MiCo BioMed Summary
• Company Overview
• Products

Nano-Ditech Corporation

• Table 17-99: Nano-Ditech Corporate Summary
• Company Overview
• Products
• COVID-19

NG Biotech

• Table 17-100: NG Biotech Corporate Summary
• Company Overview
• Products
• COVID-19

Noble Medical, Inc

• Table 17-101: Noble Medical Corporate Summary
• Company Overview
• Products

Nova Biomedical Corp.

• Table 17-102: Nova Biomedical Corporate Summary
• Company Overview
• Products

Oasis Diagnostics Corporation

• Table 17-103: Oasis Diagnostics Corporate Summary
• Company Overview
• Products

Operon S.A.

• Table 17-104: Operon Corporate Summary
• Company Overview
• Products
• COVID-19

OPKO Health, Inc

• Table 17-105: OPKO Health Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
• Table 17-106: OPKO Health Revenues (2020-2022) ($ millions)

OraSure Technologies, Inc.

• Table 17-107: OraSure Technologies Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-108: OraSure Revenues (2020-2022) ($ millions)

Polymedco, Inc

• Table 17-109: Polymedco Corporate Summary
• Company Overview
• Products

Polymer Technologies, Inc (PTS Diagnostics)

• Table 17-110: Polymer Technologies Corporate Summary
• Company Overview
• Products
• COVID-19

Preventis GmbH

• Table 17-111: Preventis Corporate Summary
• Company Overview
• Products

Princeton Biomeditech Corporation

• Table 17-112: Princeton Biomeditech Corporate Summary
• Company Overview
• Products
• Covid-19

QuantuMDx Group Limited

• Table 17-113: QuantuMDx Group Corporate Summary
• Company Overview
• Products
• COVID-19

QuidelOrtho Corporation

• Table 17-114: Quidel Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-115: QuidelOrtho Revenues (2020-2022) ($ millions)

Radiometer Medical A/S

• Table 17-116: Radiometer Medical Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-117: Radiometer (2020-2022) ($ millions)

Randox Laboratories Limited

• Table 17-118: Randox Labs Corporate Summary
• Company Overview
• Products
• COVID-19

Response Biomedical Corp

• Table 17-119: Response Biomedical Corporate Summary
• Company Overview
• Products
• COVID-19

Reszon Diagnostics International Sdn. Bhd.

• Table 17-120: Reszon Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19

Rheonix, Inc

• Table 17-121: Rheonix Corporate Summary
• Company Overview
• Products
• COVID-19

Roche Diagnostic Corporation

• Table 17-122: Roche Diagnostic Corporate Summary
• Company Overview
• Products
  • Table 17-123: Roche POC Marketed Products
• COVID-19
• Performance Review
  • Table 17-124: Roche Diagnostics (2020-2022) ($ millions)

Savyon Diagnostics

• Table 17-125: Savyon Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19

Sekisui Diagnostics LLC

• Table 17-126: Sekisui Diagnostics Corporate Summary
• Company Overview
• Products

Siemens Healthineers GmbH

• Table 17-127: Siemens Healthineers Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-128: Siemens Healthineers (2020-2022) ($ millions)

Sysmex Corporation

• Table 17-129: Sysmex Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-130: Sysmex (2020-2022) ($ millions)

TECHLAB, Inc.

• Table 17-131: TECHLAB Corporate Summary
• Company Overview
• Products

Trinity Biotech PLC

• Table 17-132: Trinity Biotech Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-133: Trinity Biotech Revenue (2020-2022) ($ millions)

Trividia Health

• Table 17-134: Trividia Health Corporate Summary
• Company Overview
• Products

Tulip Diagnostics Ltd (Tulip Group)

• Table 17-135: Tulip Diagnostics Corporate Summary
• Company Overview
• Product
• COVID-19

VedaLab

• Table 17-136: VedaLab Corporate Summary
• Company Overview
• Products
• COVID-19

Veredus Laboratories PTE Ltd

• Table 17-137: Veredus Labs Corporate Summary
• Company Overview
• Products
• COVID-19

Werfen

• Table 17-138: Werfen Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-139: Werfen (2020-2022) ($ millions)